Helicobacter pylori: From the stomach to the heart

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 11, 1999, Pages 1335-1337

  Pellicano, Rinaldo ^a,b   Broutet, Nathalie ^a   Ponzetto, Antonio ^b   Mégraud, Francis ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Coronary heart disease; Helicobacter pylori; Myocardial infarction

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; PROCOAGULANT;

ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; STROKE; THROMBOCYTE AGGREGATION;

EID: 0032711914     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199911000-00027     Document Type: Article

References (27)

1. Mendall MA, Goggin PM, Molineaux N, Levy J, Strachan D, Camm JA, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71:437-439.
2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276.
3. Heller RF, Miller NE, Wheeler MJ, Kind PR. Coronary heart disease in 'low risk' men. Atherosclerosis 1983; 49(2):187-193.
4. Heller RF, Chinn S, Pedoe HD, Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J 1984; 288(6428): 1409-1411.
5. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease - a possible trigger for acute myocardial infarction? Int J Epidemiol 1978; 7:231-239.
6. Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, et al. Association between dental health and acute myocardial infarction. Br Med J 1989; 298(6676):779-781.
7. Garfunkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350:404-407.
8. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96:404-407.
9. Hennekens CH. Increasing burden of cardiovascular disease, current knowledge and future directions for research on risk factors. Circulation 1998; 97:1095-1102.
10. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial, Risk factor changes and mortality results, J Am Med Assoc 1982; 248:1465-1477.
11. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Cell Cardiol 1998; 31:1217-1225.
12. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-436.
13. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Association between childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 1:896-897.
14. Saikku P, Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993; 14(K):62-65.
15. Ossewaarde JM, Feskens EJM, De Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol infect 1998; 120:93-99.
16. Kark JD, Leinonen M, Paltiel O, Saikku P. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 1997; 26(4):730-738.
17. Bergenzaun P, Kristinsson KG, Thjodleifsson B, Sigvaldadottir E, Molstad S, Held M, et al. Seroprevalence of Helicobacte pylori in south Sweden and Iceland. Scand J Gastroenterol 1996; 31(12):1157-1161.
18. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumor necrosis factor a and interleukin in patients with Helicobacter pylori associated gastritis. Gut 1991; 32:1473-1477.
19. Appelmelk BJ, Simons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, et al. Potential rote of molecular mimicry between Helicobacter pylori lipopolysaccharides and host Lewis blood group antigens in autoimmunity. Infect Immun 1996; 64:2031-2040.
20. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hills WS, Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998; 19(3):387-394.
21. Sung JJK, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori and coronary heart disease. Heart 1996; 76:305-307.
22. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J, et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997; 100:996-1005.
23. Aguejouf O, Mayo K, Malfatti E, Doutremepuich C, Mégraud F. Arterial thrombosis and chronic Helicobacter pylori infection in mice [Abstract]. Gut 1998; 43(suppl 2):A104.
24. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995; 311:711-714.
25. Parente F, Maconi G, Imbesi V, Sangaletti O, Poggio M, Rossi E, et al. Helicobacter pylori infection and coagulation in healthy people. Br Med J 4997; 314:1318-1319.
26. Miragliotta G, Del Prate R, Mosca A. Helicobacter pylori and coronary head disease. Lancet 1994; 344:751.
27. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Dr Med J 1998; 316:1130-1132.